Public-registry site landscape for NCT02156843, a Diabetic Nephropathy study sponsored by NephroGenex, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT02156843 (registry record) |
| Sponsor | NephroGenex, Inc. |
| Condition(s) | Diabetic Nephropathy; Diabetic Kidney Disease |
| Phase | PHASE3 |
| Listed sites | 137 |
| Site countries | United States, Australia, Bulgaria, France, Germany, Hong Kong, Hungary, Israel, Mauritius, Poland, Puerto Rico, Spain |
Eichor generates a preliminary site-risk snapshot for NCT02156843 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →